Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03114397
Other study ID # 2014/113b
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2017
Est. completion date December 24, 2021

Study information

Verified date November 2022
Source University of Liege
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this multicentric double-blind sham controlled study, the investigators plan to assess the effects of 20 sessions of tDCS on long-term behavioral recovery in patients with disorders of consciousness. Neurophysiological outcomes (EEG) will also be collected. This research will 1) determine whether long-term behavioral recovery can be promoted with tDCS and 2) generate knowledge regarding the impact of tDCS on neurophysiological outcome (i.e., EEG) in severely brain injured patients. The investigators will compare the effects of active and sham tDCS on behavioral assessments and quantitative EEG in patients with severe brain injury and its potential application in rehabilitation.


Recruitment information / eligibility

Status Completed
Enrollment 62
Est. completion date December 24, 2021
Est. primary completion date December 24, 2021
Accepts healthy volunteers No
Gender All
Age group 16 Years to 80 Years
Eligibility Inclusion Criteria: - CNS medication stable for at least a week - Stable diagnosis (no diagnosis change based on 2 CRS-R performed within 1 week). - Between 3 and 24 months post injury - Structural MRI or CT-scan (to evidence focal lesions on the left DLPFC) Exclusion Criteria: - Craniotomies encompassing the frontal region (electrodes location) - VPS under the stimulated area (prefrontal cortex) - Pacemaker - Metallic cerebral implant - Severe medical conditions that might influence clinical diagnosis and EEG activity (e.g., severe hepatic insufficiency or renal failure, or sub-continuous or abundant epileptiform discharges on standard EEG recordings).

Study Design


Related Conditions & MeSH terms


Intervention

Device:
transcranial direct current stimulation - active
transcranial direct current stimulation will be applied over the left dorsolateral at 2 mA for 20minutes.
transcranial direct current stimulation - sham
transcranial direct current stimulation will be applied over the left dorsolateral at 2 mA for 20minutes. The sham intervention consists of 30 seconds of stimulation at the beginning and the end of the 20minutes of intervention.

Locations

Country Name City State
Belgium University of Liege Liege

Sponsors (10)

Lead Sponsor Collaborator
University of Liege Azienda Unita Sanitaria Locale di Piacenza, Italy, Fondazione Salvatore Maugeri, Italy, Hospitales Nisa, Spain, I.R.C.C.S. Fondazione Santa Lucia, Italy, pavlov state medical university, Russia, Research Center of Neurology, Russia, Schoen Clinic Bad Aibling, Germany, Therapiezentrum Burgau, Germany, Université Catholique de Louvain, Belgium

Country where clinical trial is conducted

Belgium, 

References & Publications (2)

Thibaut A, Bruno MA, Ledoux D, Demertzi A, Laureys S. tDCS in patients with disorders of consciousness: sham-controlled randomized double-blind study. Neurology. 2014 Apr 1;82(13):1112-8. doi: 10.1212/WNL.0000000000000260. Epub 2014 Feb 26. — View Citation

Thibaut A, Wannez S, Donneau AF, Chatelle C, Gosseries O, Bruno MA, Laureys S. Controlled clinical trial of repeated prefrontal tDCS in patients with chronic minimally conscious state. Brain Inj. 2017;31(4):466-474. doi: 10.1080/02699052.2016.1274776. Epub 2017 Mar 10. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in the CRS-R total score Improvement of the CRS-R total score after the end of the anodal session. 4 weeks
See also
  Status Clinical Trial Phase
Completed NCT05954650 - Clinical Validity of the Minimally Conscious State "Plus" and "Minus"
Suspended NCT04244058 - Changes in Glutamatergic Neurotransmission of Severe TBI Patients Early Phase 1
Not yet recruiting NCT05833568 - Five-day 20-minute 10-Hz tACS in Patients With a Disorder of Consciousness N/A
Recruiting NCT05219331 - Hydrocephalus Treatment on Persistent Disorder of Consciousness N/A
Recruiting NCT05706831 - Music Intervention and Transcranial Electrical Stimulation for Neurological Diseases N/A
Active, not recruiting NCT03623828 - Treating Severe Brain-injured Patients With Apomorphine Phase 2
Active, not recruiting NCT05734183 - Multisensorial IMmersive Experiences (MIME) in Disorders of Consciousness N/A
Recruiting NCT05714215 - SECONDs' Italian Translation and Transcultural Validation
Completed NCT04035655 - Sub-study of the NEURODOC Project : Neurophysiological Evaluation of a Routine Care Open Label tDCS Session N/A
Active, not recruiting NCT05747170 - Olfactory Stimulation in Severe Brain Injury N/A
Active, not recruiting NCT03826407 - Development of a Point of Care System for Automated Coma Prognosis
Recruiting NCT03576248 - CONsciousness Transcranial Electric STimulation N/A
Recruiting NCT03611166 - Proteomics for Chronic Disorder of Consciousness
Recruiting NCT05382260 - Personal Music for Disorders of Consciousness N/A
Not yet recruiting NCT05820178 - tDCS and rTMS in Patients With Early Disorders of Consciousness N/A
Recruiting NCT05343507 - Ketamine to Treat Patients With Post-comatose Disorders of Consciousness Phase 2/Phase 3
Completed NCT05536921 - Eye Tracking Technology in the Diagnosis of Neurological Patients
Recruiting NCT05740735 - Emotional and Neutral Sounds for Neurophysiological Prognostic Assessment of Critically Ill Patients With a Disorder of Consciousness
Completed NCT02647996 - Functional Connectivity Measurement After Severe Traumatic Brain Injury
Completed NCT04530968 - Metabolic Abnormalities and Intestinal Microecology in Patients With Chronic Disorders of Consciousness